Literature DB >> 21091359

The association of low-grade systemic inflammation with hypertensive retinopathy.

Erkan Coban1, Ilknur Nizam, Cansu Topal, Yusuf Akar.   

Abstract

High-sensitivity C-reactive protein (hs-CRP) is a marker of systemic low-grade inflammation. The pathophysiologic mechanism of hypertensive retiopathy (HR) is not fully established. Elevated blood pressure (BP) alone does not fully account for the extent of retinopathy, other pathogenic mechanisms may be involved, such as low-grade inflammation. Therefore, this study was designed to answer the following questions. (i) Do hs-CRP levels change in HR? (ii) Is there any relation between degree of HR and hs-CRP levels? This study included 84 hypertensive patients with HR. The hypertensive patients were divided into two groups according to the Keith-Wagener classification. Group 1 comprised 42 patients with grade I HR, and Group 2 comprised 42 patients with grade II HR. We selected 42 healthy subjects matched for age, sex, and body mass index (BMI) for control group. The level of hs-CRP in group 2 was significantly higher than in group 1 group (p = 0.018) and control group (p = 0.001), it was also higher in group 1 than in control group (p = 0.002). Also, hs-CRP showed positive correlations with degree of HR (r = 0.29, p = 0.017). Our study suggests that there is a relationship between HR and hs-CRP levels, which may be associated with systemic low- grade inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091359     DOI: 10.3109/10641963.2010.496519

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  11 in total

1.  FELLOW EYE CHANGES IN PATIENTS WITH NONISCHEMIC CENTRAL RETINAL VEIN OCCLUSION: Assessment of Perfused Foveal Microvascular Density and Identification of Nonperfused Capillaries.

Authors:  Alexander Pinhas; Michael Dubow; Nishit Shah; Eric Cheang; Chun L Liu; Moataz Razeen; Alexander Gan; Rishard Weitz; Yusufu N Sulai; Toco Y Chui; Alfredo Dubra; Richard B Rosen
Journal:  Retina       Date:  2015-10       Impact factor: 4.256

2.  Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet.

Authors:  Islam N Mohamed; Sherif S Hafez; Arwa Fairaq; Adviye Ergul; John D Imig; Azza B El-Remessy
Journal:  Diabetologia       Date:  2013-11-08       Impact factor: 10.122

3.  Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension.

Authors:  S A M Kolman; A M van Sijl; F A van der Sluijs; M A van de Ree
Journal:  J Hum Hypertens       Date:  2016-07-28       Impact factor: 3.012

4.  Study of ischemia modified albumin (IMA) as a biomarker in hypertensive retinopathy.

Authors:  Ecaterina Pavlovschi; Valeriana Pantea; Djina Borovic; Olga Tagadiuc
Journal:  Med Pharm Rep       Date:  2021-04-29

5.  Diabetes exacerbates retinal oxidative stress, inflammation, and microvascular degeneration in spontaneously hypertensive rats.

Authors:  Islam N Mohamed; Sahar A Soliman; Ahmed Alhusban; Suraporn Matragoon; Bindu A Pillai; Ahmed A Elmarkaby; Azza B El-Remessy
Journal:  Mol Vis       Date:  2012-06-02       Impact factor: 2.367

6.  The association between endothelial dysfunction and hypertensive retinopathy in essential hypertension.

Authors:  Mustafa Karaca; Erkan Coban; Sebahat Ozdem; Mustafa Unal; Ozan Salim; Orhan Yucel
Journal:  Med Sci Monit       Date:  2014-01-19

7.  Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension.

Authors:  Rahul B Dange; Deepmala Agarwal; Ryoichi Teruyama; Joseph Francis
Journal:  J Neuroinflammation       Date:  2015-02-18       Impact factor: 8.322

8.  Glutathione-related antioxidant defense system in patients with hypertensive retinopathy.

Authors:  Pavlovschi Ecaterina; Pantea Valeriana; Borovic Djina; Tagadiuc Olga
Journal:  Rom J Ophthalmol       Date:  2021 Jan-Mar

9.  Serum uric acid concentration is associated with hypertensive retinopathy in hypertensive chinese adults.

Authors:  Xuling Chen; Ying Meng; Jun Li; Hiacheng She; Liang Zhao; Jing Zhang; Yuan Peng; Kun Shang; Yadi Zhang; Xiaopeng Gu; Wenbin Yang; Yan Zhang; Jianping Li; Xianhui Qin; Binyan Wang; Xiping Xu; Fanfan Hou; Genfu Tang; Rongfeng Liao; Yong Huo; Liu Yang
Journal:  BMC Ophthalmol       Date:  2017-06-02       Impact factor: 2.209

10.  Long-term inhibition of UCHL1 decreases hypertension and retinopathy in spontaneously hypertensive rats.

Authors:  Shasha Liu; Chengfang Wang; Jianmin Lu; Guangzheng Dai; Huixin Che; Wei He
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.